Cart
sales@molnova.com
L755507
CAS No. 159182-43-1
L755507( L-755507 | L 755507 | L755507 )
Catalog No. M17337 CAS No. 159182-43-1
L755507 is an effective, selective agonist of β3-AR(IC50=35 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 98 | In Stock |
|
| 10MG | 158 | In Stock |
|
| 25MG | 282 | In Stock |
|
| 50MG | 421 | In Stock |
|
| 100MG | 606 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameL755507
-
NoteResearch use only, not for human use.
-
Brief DescriptionL755507 is an effective, selective agonist of β3-AR(IC50=35 nM).
-
DescriptionL-755507 is a potent β3-adrenergic receptor partial agonist > 1000-fold selective over β1- and β2-adrenoceptors (EC50 values are 0.43, 580 and > 10000 nM for activation of cloned human β3-, β1- and β2-adrenoceptors respectively). L-755507 stimulates lipolysis in rhesus adipocytes in vitro (EC50 = 3.9 nM).
-
In Vitro——
-
In Vivo——
-
SynonymsL-755507 | L 755507 | L755507
-
PathwayTyrosine Kinase
-
TargetBcr-Abl
-
Recptorβ1-adrenergic receptor| β2-adrenergic receptor| β2-adrenergic receptor
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number159182-43-1
-
Formula Weight584.73
-
Molecular FormulaC30H40N4O6S
-
Purity>98% (HPLC)
-
SolubilityDMSO : 125 mg/mL. 213.77 mM;
-
SMILESCCCCCCNC(=O)Nc1ccc(cc1)S(=O)(=O)Nc1ccc(CCNC[C@H](O)COc2ccc(O)cc2)cc1
-
Chemical Name1-hexyl-3-[4-[[4-[2-[[(2S)-2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]phenyl]sulfamoyl]phenyl]urea
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yu C, et al. Cell Stem Cell. 2015, 16(2):142-147.
molnova catalog
related products
-
ZM 306416
ZM 306416 is a VEGFR (Flt and KDR) inhibitor for VEGFR1 with IC50 of 0.33 μM, but also found to inhibit EGFR with IC50 of <10 nM.
-
PP1
PP1 is a potent and selective Src inhibitor for Lck/Fyn with IC50 of 5 nM/ 6 nM.
-
Rasagiline
Rasagiline is an irreversible inhibitor of monoamine oxidase and is used as a monotherapy in early Parkinson's disease or as an adjunct therapy in more advanced cases.
